Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents

Stopped Enrollment challenges and change in development plan necessitating a change in study design

Conditions

• Urinary Tract Infections
• Pyelonephritis Acute
• Intraabdominal Infections

Interventions

• DRUG: Sulopenem

Sponsor

Iterum Therapeutics, International Limited